Literature DB >> 35050764

Gene Expression Profile-Based Risk Modeling to Select Patients With Melanoma Who Can Avoid Sentinel Lymph Node Biopsy: Are We There Yet?

Edmund K Bartlett1, Michael A Marchetti1, Daniel G Coit1.   

Abstract

Entities:  

Year:  2020        PMID： 35050764     DOI： 10.1200/PO.20.00146

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN： 2473-4284


× No keyword cloud information.
  1 in total

Review 1.  Breslow thickness 2.0: Why gene expression profiling is a step toward better patient selection for sentinel lymph node biopsies.

Authors:  Mariana B Sadurní; Alexander Meves
Journal:  Mod Pathol       Date:  2022-06-02       Impact factor: 8.209
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.